St. Nicholas Private Asset Management’s AbbVie ABBV Stock Holding History

St. Nicholas Private Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.56M	Sell	34,003 -110	-0.3%	-$23.7K	7.46%	2
2026 Q1	$7.42M	Sell	34,113 -1,817	-5%	-$403K	6.94%	3
2025 Q4	$8.21M	Sell	35,930 -467	-1%	-$106K	7.36%	3
2025 Q3	$8.43M	Sell	36,397 -369	-1%	-$75.1K	7.31%	3
2025 Q2	$6.82M	Buy	36,766 +306	+0.8%	+$56.9K	6.33%	4
2025 Q1	$7.64M	Sell	36,460 -1,707	-4%	-$332K	7.24%	4
2024 Q4	$6.78M	Buy	+38,167	New	+$7.02M	6.06%	4

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

St. Nicholas Private Asset Management's ABBV Position: Q2 2026 in Review

St. Nicholas Private Asset Management reduced its AbbVie (ABBV) stake by 0.32% in Q2 2026, selling an estimated $23.7K and leaving 34,003 shares worth $8.56M. The position accounts for 7.46% of the portfolio, ranked #2.

St. Nicholas Private Asset Management first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

St. Nicholas Private Asset Management held 34,003 shares of AbbVie worth $8.56M as of Q2 2026.
St. Nicholas Private Asset Management sold 110 AbbVie shares in Q2 2026, an estimated $23.7K.
AbbVie made up 7.46% of St. Nicholas Private Asset Management's portfolio in Q2 2026, its #2 holding.
St. Nicholas Private Asset Management first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on St. Nicholas Private Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.